Intellipharmaceutics names new CFO
This article was originally published in Scrip
Executive Summary
Intellipharmaceutics International (Canada) has appointed Graham Neil chief financial officer and vice-president of finance. He has more than 10 years' public company and healthcare industry experience, having most recently served as CFO for a Nasdaq- and TSX-listed development-stage company. Intellipharmaceutics is a speciality pharmaceutical company focused on the R&D and manufacture of controlled and targeted oral solid dose drugs.